Aescap
Aescap is an Amsterdam-based investment company specializing in listed biotech and life sciences companies with exceptional growth potential. It operates two main funds, the Aescap Life Sciences Fund and the Aescap Genetics Fund, investing in innovative publicly traded biotech companies focused on treatments for diseases lacking effective medicines, such as Alzheimer's, cancer, and cardiovascular diseases. The company employs a multidisciplinary investment team with deep biotech expertise and significant personal investment in the funds, applying fundamental analysis and active engagement with portfolio companies. Aescap aims to deliver excellent financial returns while impacting global health, leveraging trends like AI in medicine development and demographic growth. The funds are regulated under EU sustainable finance standards and overseen by Dutch financial authorities.
Aescap
Aescap is an Amsterdam-based investment company specializing in listed biotech and life sciences companies with exceptional growth potential. It operates two main funds, the Aescap Life Sciences Fund and the Aescap Genetics Fund, investing in innovative publicly traded biotech companies focused on treatments for diseases lacking effective medicines, such as Alzheimer's, cancer, and cardiovascular diseases. The company employs a multidisciplinary investment team with deep biotech expertise and significant personal investment in the funds, applying fundamental analysis and active engagement with portfolio companies. Aescap aims to deliver excellent financial returns while impacting global health, leveraging trends like AI in medicine development and demographic growth. The funds are regulated under EU sustainable finance standards and overseen by Dutch financial authorities.